Published in Bioconjug Chem on March 18, 2009
Development of 18F-labeled picolinamide probes for PET imaging of malignant melanoma. J Med Chem (2013) 0.97
PET/CT in malignant melanoma: contrast-enhanced CT versus plain low-dose CT. Eur J Nucl Med Mol Imaging (2011) 0.86
Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [¹⁰F]ICF01006, a highly promising melanoma PET tracer. Eur J Nucl Med Mol Imaging (2012) 0.85
A novel aliphatic 18F-labeled probe for PET imaging of melanoma. Mol Pharm (2013) 0.81
Imaging malignant melanoma with (18)F-5-FPN. Eur J Nucl Med Mol Imaging (2015) 0.81
Synthesis and preclinical characterization of [18F]FPBZA: a novel PET probe for melanoma. Biomed Res Int (2014) 0.77
In Vivo Imaging of Experimental Melanoma Tumors using the Novel Radiotracer (68)Ga-NODAGA-Procainamide (PCA). J Cancer (2017) 0.75
PET and SPECT imaging of melanoma: the state of the art. Eur J Nucl Med Mol Imaging (2017) 0.75
Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling. Eur J Pharmacol (1994) 2.29
Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res (1995) 2.18
An admonition when measuring the lipophilicity of radiotracers using counting techniques. Appl Radiat Isot (2001) 1.36
Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments. Cancer Res (1985) 1.06
In vivo evaluation of 99mTc/188Re-labeled linear alpha-melanocyte stimulating hormone analogs for specific melanoma targeting. Nucl Med Biol (1999) 1.03
Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma. Cancer (2005) 1.02
Fully automated preparation of n.c.a. 4-[18F]fluorobenzoic acid and N-succinimidyl 4-[18F]fluorobenzoate using a Siemens/CTI chemistry process control unit (CPCU). Appl Radiat Isot (2006) 1.01
Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma. J Clin Oncol (2001) 0.99
Visualization of ocular melanoma with N-isopropyl-p-[123I]-iodoamphetamine. J Nucl Med (1988) 0.95
Synthesis and preliminary evaluation of para- and meta-[18F]fluorobenzylguanidine. Nucl Med Biol (1994) 0.95
Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide). J Nucl Med (1993) 0.95
Peptide-targeted radionuclide therapy for melanoma. Crit Rev Oncol Hematol (2008) 0.93
A malignant melanoma imaging agent: synthesis, characterization, in vitro binding and biodistribution of iodine-125-(2-piperidinylaminoethyl)4-iodobenzamide. J Nucl Med (1993) 0.92
Baseline staging in cutaneous malignant melanoma. Br J Dermatol (2004) 0.92
Enhanced binding and inertness to dehalogenation of alpha-melanotropic peptides labeled using N-succinimidyl 3-iodobenzoate. Bioconjug Chem (1997) 0.90
Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma. J Nucl Med (1991) 0.89
123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging. Eur J Nucl Med Mol Imaging (2002) 0.89
Radioiodinated N-(2-diethylaminoethyl)benzamide derivatives with high melanoma uptake: structure-affinity relationships, metabolic fate, and intracellular localization. J Med Chem (2000) 0.86
A role for FDG-PET in the surgical management of stage IV melanoma. Ann Surg Oncol (2004) 0.86
Synthesis and characterization of [125I]-N-(N-benzylpiperidin-4-yl)-4- iodobenzamide, a new sigma receptor radiopharmaceutical: high-affinity binding to MCF-7 breast tumor cells. J Med Chem (1994) 0.85
Examination of four 123I-labeled piperidine-based sigma receptor ligands as potential melanoma imaging agents: initial studies in mouse tumor models. Nucl Med Biol (1997) 0.84
Synthesis and evaluation of novel radioiodinated benzamides for malignant melanoma. J Med Chem (2007) 0.84
Synthesis, characterization and comparative biodistribution study of a new series of p-iodine-125 benzamides as potential melanoma imaging agents. Nucl Med Biol (2001) 0.83
Pharmacokinetics of iodine-123-IMBA for melanoma imaging. J Nucl Med (1997) 0.81
Scintigraphic detection of melanoma metastases with a radiolabeled benzamide ([iodine-123]-(S)-IBZM). J Nucl Med (1994) 0.81
Uptake in melanoma cells of N-(2-diethylaminoethyl)-2-iodobenzamide (BZA2), an imaging agent for melanoma staging: relation to pigmentation. Nucl Med Biol (2005) 0.78
Structure distribution relationship of iodine-123-iodobenzamides as tracers for the detection of melanotic melanoma. J Nucl Med (1996) 0.78
[Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma]. J Fr Ophtalmol (2004) 0.77
Synthesis and pharmacological characterization of 4-[125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide: a high affinity sigma receptor ligand for potential imaging of breast cancer. Cancer Res (1995) 0.77
In vivo evaluation of [123I]-4-iodo-N-(4-(4-(2-methoxyphenyl)-piperazin-1-yl)butyl)-benzamide: a potential sigma receptor ligand for SPECT studies. Nucl Med Biol (2005) 0.77
N-(2-diethylaminoethyl)-4-[123I]iodobenzamide as a tracer for the detection of malignant melanoma: simple synthesis, improved labelling technique and first clinical results. Eur J Nucl Med (1993) 0.77
Iodide benzamides for the in-vivo detection of melanoma and metastases. Melanoma Res (2006) 0.77
131I-metaiodobenzylguanidine (mIBG) for bronchial oat cell cancer and melanoma detection? Eur J Nucl Med (1989) 0.77
Detection of malignant melanoma with iodine-123 iodoamphetamine. J Nucl Med (1988) 0.77
Limited sensitivity of iodine-123-2-hydroxy-3-iodo-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl ] benzamide whole-body scintigraphy in patients with malignant melanoma: a comparison with thallium-201 imaging. Eur J Nucl Med (1999) 0.77
Detection of ocular melanoma with 4-(3-dimethylaminopropylamino)-7-[123I]-iodoquinoline. J Nucl Med (1984) 0.77
Diagnostic efficacy of a radioiodinated chloroquine analog in patients with malignant melanoma. J Nucl Med (1970) 0.77
MRI and PET study of deficits in hippocampal structure and function in women with childhood sexual abuse and posttraumatic stress disorder. Am J Psychiatry (2003) 2.51
Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry (2003) 1.77
Kinetics of brain nicotine accumulation in dependent and nondependent smokers assessed with PET and cigarettes containing 11C-nicotine. Proc Natl Acad Sci U S A (2010) 1.21
Recent trends in antibody-based oncologic imaging. Cancer Lett (2011) 1.17
Effect of menstrual cycle phase on dopamine D2 receptor availability in female cynomolgus monkeys. Neuropsychopharmacology (2008) 1.09
Diagnosis of histoplasmosis on lymph node fine needle aspiration cytology utilizing Giemsa stain: a report of three cases. Anal Quant Cytopathol Histpathol (2014) 1.08
Social dominance in female monkeys: dopamine receptor function and cocaine reinforcement. Biol Psychiatry (2012) 0.97
Effects of cocaine and MDMA self-administration on serotonin transporter availability in monkeys. Neuropsychopharmacology (2007) 0.86
Effects of nicotinic acetylcholine receptor agonists on cognition in rhesus monkeys with a chronic cocaine self-administration history. Neuropharmacology (2012) 0.86
99mTc-labeled annexin V fragments: a potential SPECT radiopharmaceutical for imaging cell death. Nucl Med Biol (2006) 0.85
3-Amino-4-(2-((4-[18F]fluorobenzyl)methylamino)methylphenylsulfanyl)benzonitrile, an F-18 fluorobenzyl analogue of DASB: synthesis, in vitro binding, and in vivo biodistribution studies. Bioconjug Chem (2007) 0.83
Effects of repeated treatment with the dopamine D2/D3 receptor partial agonist aripiprazole on striatal D2/D3 receptor availability in monkeys. Psychopharmacology (Berl) (2013) 0.82
In vivo biodistribution of an androgen receptor avid PET imaging agent 7-alpha-fluoro-17 alpha-methyl-5-alpha-dihydrotestosterone ([(18)F]FMDHT) in rats pretreated with cetrorelix, a GnRH antagonist. Eur J Nucl Med Mol Imaging (2007) 0.82
Imaging of pheochromocytoma in 2 dogs using p-[18F] fluorobenzylguanidine. Vet Radiol Ultrasound (2002) 0.81
Preparation and in-vivo evaluation of (188)Re(CO)(3)-colchicine complex for use as tumor-targeting agent. Cancer Biother Radiopharm (2008) 0.76
Synthesis and evaluation of ether containing 99mTc-nitrido dithiocarbamate complexes as brain perfusion imaging agent. Appl Radiat Isot (2005) 0.76
A remote controlled system for the preparation of 7 alpha-[18F]fluoro-17 alpha-methyl 5 alpha-dihydrotestosterone ([18F]FMDHT) using microwave. Appl Radiat Isot (2008) 0.75
Studies on the influence of the structural modifications in the tracer on the immunoassay of progesterone. J Immunoassay Immunochem (2006) 0.75
Preparation and in vivo evaluation of (99m)TcN-tertiary butyl xanthate as a potential myocardial agent. Appl Radiat Isot (2006) 0.75
Splendore-Hoeppli phenomenon on fine needle aspiration cytology of subcutaneous inflammatory lesions. Anal Quant Cytopathol Histpathol (2014) 0.75
Utility of the Paris System in Reporting Urine Cytology. Acta Cytol (2017) 0.75
99mTc-labeling of colchicine using [99mTc(CO)3(H2O)3]+ and [99mTc triple bond N]2+ core for the preparation of potential tumor-targeting agents. Bioorg Med Chem (2005) 0.75
Synthesis of 99mTc-nitrido heterocomplex of piperidine and in vitro and in vivo evaluation of its affinity for sigma receptors. Cancer Biother Radiopharm (2008) 0.75
Human Immunodeficiency Virus Lymphadenitis Patterns on Fine-Needle Aspiration Cytology. Acta Cytol (2016) 0.75
Preparation and bioevaluation of 99mTc-carbonyl complex of 5-hydroxy tryptamine derivative. Appl Radiat Isot (2006) 0.75
Fine-needle aspiration cytology of breast lesions with spontaneous infarction: a five-year study. Acta Cytol (2013) 0.75
Radiosynthesis of [18F] N-(3-Fluoropropyl)-2-beta-Carbomethoxy-3-beta-(4-Bromophenyl) Nortropane and the regional brain uptake in non human primate using PET. Nucl Med Biol (2004) 0.75